ProCE Banner Activity

Targeting the MDM2-p53 Pathway in Biliary Tract Cancer: Emerging Data and Implications for Future Clinical Practice

Slideset

Downloadable slideset on the current guidelines and recommendations for molecular testing in advanced BTC, rationale for targeting MDM2/p53 signaling in BTC, and potential future role of MDM2 inhibitors in BTC from Patricia LoRusso, DO, PhD(h).

Released: August 29, 2024

Expiration: August 28, 2025

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

Boehringer Ingelheim Pharmaceuticals, Inc.